During the past decade, Investigaciones Clinicas Moleculares (ICM) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Investigaciones Clinicas Moleculares (ICM)" are "Abiraterone Acetate" (1 trials), "Androgens" (1 trials), "Antineoplastic Agents" (1 trials), "Antineoplastic Agents, Hormonal" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Investigaciones Clinicas Moleculares (ICM)" in a lesser frequency.

Most popular intervention types in "Investigaciones Clinicas Moleculares (ICM)" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (1 trials), "Abiraterone" (1 trials), "Anastrozole" (1 trials), "Exemestane" (1 trials) and "Imlunestrant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Investigaciones Clinicas Moleculares (ICM)" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Investigaciones Clinicas Moleculares (ICM)". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Investigaciones Clinicas Moleculares (ICM), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Investigaciones Clinicas Moleculares (ICM), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".